Research is showing that patients with chronic asthma who take the medication Serevent on a daily basis are at an increased risk for serious adverse effects.
A 12-week review of 32 clinical trials that involved 62,630 patients suggest that the collaborative use of inhaled corticosteroids with Serevent may help reduce the adverse effects. The studies in the review took randomly assigned patients who were administered either regular Serevent, a placebo, or the medication Salbutamol. 2380 of these patients were children.
Serevent is a long-acting, beta2 adrenergic receptor agonist that is delivered as a dry powder and administered with an inhaler. It is prescribed for long-term use for the treatment of Chronic Obstructive Pulmonary Disease (COPD), including emphysema and chronic bronchitis. Side effects include throat irritation, sinus headache, nausea, sleep disturbance, tingling, eczema and pyrexia and increased body temperature
